Global Vascular Access Device Market Size to Grow at a CAGR of 6.40% During 2025-2032 | DelveInsight

The Vascular Access Device Market was valued at approximately USD 5,450.01 million in 2024 and is projected to reach around USD 8,413.65 million by 2032.

DelveInsight's Vascular Access Device Market Insights Report 2032 provides a comprehensive assessment of the current and forecast market, leading Vascular Access Device companies, market shares, market drivers, barriers, trends, opportunities, and competitive landscape.

To read more about the latest highlights related to the Vascular Access Device Market:
https://www.delveinsight.com/report-store/vascular-access-device-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Key Takeaways from the Vascular Access Device Market Report

* In September 2025, PatenSee received U.S. FDA Breakthrough Device Designation for its non-contact vascular access management technology for hemodialysis patients. This designation could help accelerate the development and adoption of innovative vascular access solutions in dialysis care.
* In September 2024, B. Braun Medical Inc. received U.S. FDA 510(k) clearance for its Introcan Safety 2 Deep Access IV Catheter, expanding its safety-engineered peripheral IV catheter portfolio.
* In January 2022, ICU Medical Inc. completed its acquisition of Smiths Medical from Smiths Group plc, creating a major global infusion therapy company with estimated pro forma combined revenues of approximately USD 2.5 billion.
* The global Vascular Access Device Market is expected to grow at a CAGR of 6.40% during the forecast period from 2025 to 2032.
* Market growth is being supported by the rising prevalence of chronic diseases, increasing demand for long-term intravenous therapies, technological advancements in vascular access devices, and growing utilization in chemotherapy, dialysis, and parenteral nutrition.
* Key Vascular Access Device Companies include Cook, BD, Teleflex Incorporated, Medtronic, Asahi Kasei Corporation, B. Braun SE, PRODiMED, AMECATH, Terumo Corporation, AngioDynamics, ICU Medical, Inc., Nipro Medical Corporation, Medline Industries, LP, Access Vascular, Inc., Vygon Group, Cordis, Merit Medical Systems, Cardinal Health, Fresenius SE & Co. KGaA, and Argon Medical Devices, among others.

To know more about why North America is leading the Vascular Access Device Market:
https://www.delveinsight.com/report-store/vascular-access-device-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Vascular Access Device Market Overview

Vascular access devices are medical devices used to establish reliable access to a patient's vascular system for administering medications, fluids, blood products, and other therapies, as well as for blood sampling. Common vascular access devices include peripheral intravenous catheters, central venous catheters, peripherally inserted central catheters, and implantable ports.
These devices are selected according to the patient's clinical condition, treatment duration, and therapeutic requirements. They play an important role in the management of both acute and chronic conditions by supporting efficient treatment delivery while reducing the need for repeated needle insertions.

Vascular Access Device Market Key Growth Drivers

* According to DelveInsight analysis, the number of new cancer cases is projected to increase from approximately 21.5 million in 2025 to around 32.5 million by 2045. This growing cancer burden is expected to increase demand for vascular access devices used for chemotherapy and supportive treatments.
* Cardiovascular diseases continue to contribute to demand for reliable vascular access solutions. Approximately 60.05 million people globally are affected by atrial fibrillation, while nearly 205 million people are affected by coronary heart disease.
* Chronic kidney disease affects approximately 35.7 million adults, representing around 14% of the U.S. population in 2024. Increasing dialysis requirements are expected to support demand for vascular access solutions.
* Technological advancements, including antimicrobial coatings, safety-engineered designs, bioresorbable materials, AI integration, wireless connectivity, and device miniaturization, are improving the functionality and safety of vascular access products.
* The growing geriatric population, which has a higher incidence of chronic diseases and hospitalizations, is contributing to increased demand for vascular access devices across hospitals, outpatient facilities, and home-care settings.
* Product innovation is further supporting market growth. In July 2025, Piccolo Medical received U.S. FDA 510(k) clearance for its next-generation SmartPICC Stylet and PM2+ System, designed to streamline PICC insertion and improve placement accuracy.

Get a sneak peek at the Vascular Access Device Market Dynamics:
https://www.delveinsight.com/report-store/vascular-access-device-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Vascular Access Device Market Segment Analysis

The Vascular Access Device Market is segmented by Device Type, Route of Insertion, End User, and Geography.

By Device Type

The Central Vascular Access Devices segment accounted for approximately 58% of the market share in 2024. The segment's leading position is attributed to the versatility, long-term usability, and importance of these devices in managing complex medical conditions.

Central vascular access devices, including PICCs, tunneled catheters, and implantable ports, are widely used for chemotherapy, parenteral nutrition, and other long-term intravenous therapies. Advancements in antimicrobial coatings, anti-thrombogenic technologies, and image-guided placement are further supporting their adoption.

By Route of Insertion

The Intravenous segment accounted for approximately 75% of the market in 2024. Its dominance is supported by widespread clinical use, ease of administration, and applicability across emergency care, surgical procedures, and routine hospital treatments.

The increasing availability of safety-engineered devices and integrated monitoring technologies is also contributing to the continued adoption of intravenous vascular access solutions.

By End User

Hospitals represented the largest end-user segment, accounting for more than 56% of the overall market revenue. The segment's leading position is associated with high patient volumes, the need for complex and continuous intravenous therapies, availability of trained healthcare professionals, and increasing adoption of advanced vascular access technologies.

By Geography

North America, led by the United States, dominated the Vascular Access Device Market with approximately 49% of the market share in 2024. The region's leadership is supported by the high prevalence of chronic diseases, an aging population, advanced healthcare infrastructure, and continued technological innovation.

Asia-Pacific is anticipated to be the fastest-growing regional market, supported by increasing healthcare expenditure, a growing burden of chronic diseases, and a large and aging population. India is expected to register significant growth during the forecast period.

Explore the MedTech companies shaping the future of the Vascular Access Device Market:
https://www.delveinsight.com/report-store/vascular-access-device-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Vascular Access Device Market Competitive Landscape

The Vascular Access Device Market is moderately consolidated, with established companies such as Medtronic, Becton Dickinson, Baxter International, and Smiths Medical maintaining significant positions across various product categories.

Leading companies are focusing on research and development, product innovation, strategic collaborations, acquisitions, and portfolio expansion to strengthen their market positions. At the same time, emerging companies and startups are introducing innovative solutions, including smart PICCs, AI-enabled monitoring technologies, and minimally invasive insertion systems.

These developments are contributing to a shift toward more efficient vascular access management across hospitals, outpatient facilities, and home-care environments.

Vascular Access Device Companies

The major companies operating in the Vascular Access Device Market include:

* Cook
* BD
* Teleflex Incorporated
* Medtronic
* Asahi Kasei Corporation
* B. Braun SE
* PRODiMED
* AMECATH
* Terumo Corporation
* AngioDynamics
* ICU Medical, Inc.
* Nipro Medical Corporation
* Medline Industries, LP
* Access Vascular, Inc.
* Vygon Group
* Cordis
* Merit Medical Systems
* Cardinal Health
* Fresenius SE & Co. KGaA
* Argon Medical Devices
* And others

Vascular Access Device Market Restraints

Despite strong growth potential, the Vascular Access Device Market faces several challenges.

Catheter-related bloodstream infections, thrombosis, and other device-associated complications can negatively affect patient outcomes and increase healthcare costs and hospital stays. These safety concerns remain important considerations for healthcare providers when selecting vascular access products.

Stringent regulatory requirements across major markets can also extend product approval timelines and increase development costs. In addition, the relatively high cost of advanced devices, including antimicrobial-coated and safety-engineered catheters, may limit adoption in developing countries with constrained healthcare budgets.

Product recalls, device failures, and safety concerns can further affect clinician confidence and market adoption.

Interested in knowing the Vascular Access Device Market outlook through 2032?
https://www.delveinsight.com/report-store/vascular-access-device-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Scope of the Vascular Access Device Market Report

* Coverage: Global
* Study Period: 2022-2032
* Forecast Period: 2025-2032
* Key Companies: Cook, BD, Teleflex Incorporated, Medtronic, Asahi Kasei Corporation, B. Braun SE, PRODiMED, AMECATH, Terumo Corporation, AngioDynamics, ICU Medical, Inc., Nipro Medical Corporation, Medline Industries, LP, Access Vascular, Inc., Vygon Group, Cordis, Merit Medical Systems, Cardinal Health, Fresenius SE & Co. KGaA, Argon Medical Devices, and others
* Market Segmentation: Device Type, Route of Insertion, End User, and Geography
* Market Restraints and Regulatory Analysis
* Porter's Five Forces Analysis
* Competitive Landscape and Market Assessment
* Company and Product Profiles

Explore more information about the Vascular Access Device Market:
https://www.delveinsight.com/report-store/vascular-access-device-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Table of Contents

1. Vascular Access Device Market Report Introduction
2. Vascular Access Device Market Executive Summary
3. Vascular Access Device Market Key Factors Analysis
4. Impact Analysis
5. Regulatory Analysis
6. Vascular Access Device Market Porter's Five Forces Analysis
7. Vascular Access Device Market Assessment
8. Competitive Landscape
9. Startup Funding & Investment Trends
10. Vascular Access Device Market Company and Product Profiles
11. KOL Views
12. Project Approach
13. About DelveInsight
14. Disclaimer & Contact Us

Company Name: DelveInsight Business Research LLP
Contact Person: Kanishk Kumar
Email: info@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

This release was published on openPR.